rheumatoid arthritis
The latest news about rheumatoid arthritis: headlines, AI summaries and the full story from every source.
- Immunovant Reports Q2 2026 Financial Results and IMVT-1402 Clinical Data
- Roivant Sciences Reports Q2 2026 Results with LISRAYA Commercial Launch and Positive Clinical Data
- Spyre Therapeutics Shares Drop After Mixed Phase 2 Trial Results
- Immunovant Shares Rise on Positive Clinical Trial Results Despite Earnings Miss
- Roivant Sciences Rises on Positive Phase 2 Trial Data from Immunovant's Drug